Patient-Reported Outcomes with Chimeric Antigen Receptor-T Cell Therapy: Challenges and Opportunities

Patient-reported outcomes (PROs) are an important tool to assess the impact of a new therapy on symptom burden and health-related quality of life (HRQoL). Chimeric Antigen Receptor-T (CAR-T) cell therapies have been approved for use in relapsed or refractory leukemia and lymphoma based on promising...

全面介紹

Na minha lista:
書目詳細資料
發表在:Biol Blood Marrow Transplant
Main Authors: Chakraborty, Rajshekhar, Sidana, Surbhi, Shah, Gunjan L, Scordo, Michael, Hamilton, Betty K, Majhail, Navneet S
格式: Artigo
語言:Inglês
出版: 2018
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511294/
https://ncbi.nlm.nih.gov/pubmed/30500439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.11.025
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍